Integrated Clinical and Radiomics Approach to Assess the Treatment Outcome of Combined Chemoimmunotherapy in Extensive-Stage SCLC
Journal of Thoracic Oncology(2023)
Abstract
Small cell lung cancer (SCLC) is highly malignant with early metastasis and poor prognosis. Combined chemoimmunotherapy although improves the prognosis of extensive-stage SCLC (ES-SCLC), the survival benefits are rather limited. There is an urgent need to screen out the beneficial population.
MoreTranslated text
Key words
Extensive-stage SCLC,Chemoimmunotherapy,Radiomics
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined